Cancer Gene Therapy Market - Global Outlook and Forecast 2021-2027

Cancer Gene Therapy Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Cancer Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Gene Therapy Overall Market Size
2.1 Global Cancer Gene Therapy Market Size: 2021 VS 2027
2.2 Global Cancer Gene Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Gene Therapy Players in Global Market
3.2 Top Global Cancer Gene Therapy Companies Ranked by Revenue
3.3 Global Cancer Gene Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Gene Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cancer Gene Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Gene Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Gene Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Gene Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Gene Therapy Market Size Markets, 2021 & 2027
4.1.2 Oncolytic Virotherapy
4.1.3 Gene Transfer
4.1.4 Gene-Induced Immunotherapy
4.2 By Type - Global Cancer Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Gene Therapy Revenue, 2016-2021
4.2.2 By Type - Global Cancer Gene Therapy Revenue, 2022-2027
4.2.3 By Type - Global Cancer Gene Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Gene Therapy Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Diagnostics Centers
5.1.4 Research Institutes
5.2 By Application - Global Cancer Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Gene Therapy Revenue, 2016-2021
5.2.2 By Application - Global Cancer Gene Therapy Revenue, 2022-2027
5.2.3 By Application - Global Cancer Gene Therapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Cancer Gene Therapy Market Size, 2021 & 2027
6.2 By Region - Global Cancer Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Gene Therapy Revenue, 2016-2021
6.2.2 By Region - Global Cancer Gene Therapy Revenue, 2022-2027
6.2.3 By Region - Global Cancer Gene Therapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Cancer Gene Therapy Revenue, 2016-2027
6.3.2 US Cancer Gene Therapy Market Size, 2016-2027
6.3.3 Canada Cancer Gene Therapy Market Size, 2016-2027
6.3.4 Mexico Cancer Gene Therapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Cancer Gene Therapy Revenue, 2016-2027
6.4.2 Germany Cancer Gene Therapy Market Size, 2016-2027
6.4.3 France Cancer Gene Therapy Market Size, 2016-2027
6.4.4 U.K. Cancer Gene Therapy Market Size, 2016-2027
6.4.5 Italy Cancer Gene Therapy Market Size, 2016-2027
6.4.6 Russia Cancer Gene Therapy Market Size, 2016-2027
6.4.7 Nordic Countries Cancer Gene Therapy Market Size, 2016-2027
6.4.8 Benelux Cancer Gene Therapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Cancer Gene Therapy Revenue, 2016-2027
6.5.2 China Cancer Gene Therapy Market Size, 2016-2027
6.5.3 Japan Cancer Gene Therapy Market Size, 2016-2027
6.5.4 South Korea Cancer Gene Therapy Market Size, 2016-2027
6.5.5 Southeast Asia Cancer Gene Therapy Market Size, 2016-2027
6.5.6 India Cancer Gene Therapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Cancer Gene Therapy Revenue, 2016-2027
6.6.2 Brazil Cancer Gene Therapy Market Size, 2016-2027
6.6.3 Argentina Cancer Gene Therapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Gene Therapy Revenue, 2016-2027
6.7.2 Turkey Cancer Gene Therapy Market Size, 2016-2027
6.7.3 Israel Cancer Gene Therapy Market Size, 2016-2027
6.7.4 Saudi Arabia Cancer Gene Therapy Market Size, 2016-2027
6.7.5 UAE Cancer Gene Therapy Market Size, 2016-2027
7 Players Profiles
7.1 Adaptimmune
7.1.1 Adaptimmune Corporate Summary
7.1.2 Adaptimmune Business Overview
7.1.3 Adaptimmune Cancer Gene Therapy Major Product Offerings
7.1.4 Adaptimmune Cancer Gene Therapy Revenue in Global (2016-2021)
7.1.5 Adaptimmune Key News
7.2 Bluebird bio
7.2.1 Bluebird bio Corporate Summary
7.2.2 Bluebird bio Business Overview
7.2.3 Bluebird bio Cancer Gene Therapy Major Product Offerings
7.2.4 Bluebird bio Cancer Gene Therapy Revenue in Global (2016-2021)
7.2.5 Bluebird bio Key News
7.3 Celgene
7.3.1 Celgene Corporate Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Cancer Gene Therapy Major Product Offerings
7.3.4 Celgene Cancer Gene Therapy Revenue in Global (2016-2021)
7.3.5 Celgene Key News
7.4 Shanghai Sunway Biotech
7.4.1 Shanghai Sunway Biotech Corporate Summary
7.4.2 Shanghai Sunway Biotech Business Overview
7.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Major Product Offerings
7.4.4 Shanghai Sunway Biotech Cancer Gene Therapy Revenue in Global (2016-2021)
7.4.5 Shanghai Sunway Biotech Key News
7.5 Shenzhen SiBiono GeneTech
7.5.1 Shenzhen SiBiono GeneTech Corporate Summary
7.5.2 Shenzhen SiBiono GeneTech Business Overview
7.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Major Product Offerings
7.5.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue in Global (2016-2021)
7.5.5 Shenzhen SiBiono GeneTech Key News
7.6 SynerGene Therapeutics
7.6.1 SynerGene Therapeutics Corporate Summary
7.6.2 SynerGene Therapeutics Business Overview
7.6.3 SynerGene Therapeutics Cancer Gene Therapy Major Product Offerings
7.6.4 SynerGene Therapeutics Cancer Gene Therapy Revenue in Global (2016-2021)
7.6.5 SynerGene Therapeutics Key News
7.7 Altor BioScience
7.7.1 Altor BioScience Corporate Summary
7.7.2 Altor BioScience Business Overview
7.7.3 Altor BioScience Cancer Gene Therapy Major Product Offerings
7.4.4 Altor BioScience Cancer Gene Therapy Revenue in Global (2016-2021)
7.7.5 Altor BioScience Key News
7.8 Amgen
7.8.1 Amgen Corporate Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Cancer Gene Therapy Major Product Offerings
7.8.4 Amgen Cancer Gene Therapy Revenue in Global (2016-2021)
7.8.5 Amgen Key News
7.9 Argenx
7.9.1 Argenx Corporate Summary
7.9.2 Argenx Business Overview
7.9.3 Argenx Cancer Gene Therapy Major Product Offerings
7.9.4 Argenx Cancer Gene Therapy Revenue in Global (2016-2021)
7.9.5 Argenx Key News
7.10 BioCancell
7.10.1 BioCancell Corporate Summary
7.10.2 BioCancell Business Overview
7.10.3 BioCancell Cancer Gene Therapy Major Product Offerings
7.10.4 BioCancell Cancer Gene Therapy Revenue in Global (2016-2021)
7.10.5 BioCancell Key News
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Corporate Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Cancer Gene Therapy Major Product Offerings
7.11.4 GlaxoSmithKline Cancer Gene Therapy Revenue in Global (2016-2021)
7.11.5 GlaxoSmithKline Key News
7.12 Merck
7.12.1 Merck Corporate Summary
7.12.2 Merck Business Overview
7.12.3 Merck Cancer Gene Therapy Major Product Offerings
7.12.4 Merck Cancer Gene Therapy Revenue in Global (2016-2021)
7.12.5 Merck Key News
7.13 OncoGenex Pharmaceuticals
7.13.1 OncoGenex Pharmaceuticals Corporate Summary
7.13.2 OncoGenex Pharmaceuticals Business Overview
7.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Major Product Offerings
7.13.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue in Global (2016-2021)
7.13.5 OncoGenex Pharmaceuticals Key News
7.14 Transgene
7.14.1 Transgene Corporate Summary
7.14.2 Transgene Business Overview
7.14.3 Transgene Cancer Gene Therapy Major Product Offerings
7.14.4 Transgene Cancer Gene Therapy Revenue in Global (2016-2021)
7.14.5 Transgene Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Cancer Gene Therapy Market Opportunities & Trends in Global Market
Table 2. Cancer Gene Therapy Market Drivers in Global Market
Table 3. Cancer Gene Therapy Market Restraints in Global Market
Table 4. Key Players of Cancer Gene Therapy in Global Market
Table 5. Top Cancer Gene Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cancer Gene Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cancer Gene Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cancer Gene Therapy Product Type
Table 9. List of Global Tier 1 Cancer Gene Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Gene Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Cancer Gene Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cancer Gene Therapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cancer Gene Therapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Cancer Gene Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cancer Gene Therapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cancer Gene Therapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Cancer Gene Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cancer Gene Therapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cancer Gene Therapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cancer Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cancer Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cancer Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cancer Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cancer Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cancer Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cancer Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cancer Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cancer Gene Therapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cancer Gene Therapy Revenue, (US$, Mn), 2022-2027
Table 30. Adaptimmune Corporate Summary
Table 31. Adaptimmune Cancer Gene Therapy Product Offerings
Table 32. Adaptimmune Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 33. Bluebird bio Corporate Summary
Table 34. Bluebird bio Cancer Gene Therapy Product Offerings
Table 35. Bluebird bio Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 36. Celgene Corporate Summary
Table 37. Celgene Cancer Gene Therapy Product Offerings
Table 38. Celgene Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 39. Shanghai Sunway Biotech Corporate Summary
Table 40. Shanghai Sunway Biotech Cancer Gene Therapy Product Offerings
Table 41. Shanghai Sunway Biotech Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 42. Shenzhen SiBiono GeneTech Corporate Summary
Table 43. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Offerings
Table 44. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 45. SynerGene Therapeutics Corporate Summary
Table 46. SynerGene Therapeutics Cancer Gene Therapy Product Offerings
Table 47. SynerGene Therapeutics Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 48. Altor BioScience Corporate Summary
Table 49. Altor BioScience Cancer Gene Therapy Product Offerings
Table 50. Altor BioScience Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 51. Amgen Corporate Summary
Table 52. Amgen Cancer Gene Therapy Product Offerings
Table 53. Amgen Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 54. Argenx Corporate Summary
Table 55. Argenx Cancer Gene Therapy Product Offerings
Table 56. Argenx Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 57. BioCancell Corporate Summary
Table 58. BioCancell Cancer Gene Therapy Product Offerings
Table 59. BioCancell Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 60. GlaxoSmithKline Corporate Summary
Table 61. GlaxoSmithKline Cancer Gene Therapy Product Offerings
Table 62. GlaxoSmithKline Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 63. Merck Corporate Summary
Table 64. Merck Cancer Gene Therapy Product Offerings
Table 65. Merck Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 66. OncoGenex Pharmaceuticals Corporate Summary
Table 67. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Offerings
Table 68. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
Table 69. Transgene Corporate Summary
Table 70. Transgene Cancer Gene Therapy Product Offerings
Table 71. Transgene Cancer Gene Therapy Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Cancer Gene Therapy Segment by Type
Figure 2. Cancer Gene Therapy Segment by Application
Figure 3. Global Cancer Gene Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Gene Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cancer Gene Therapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2020
Figure 8. By Type - Global Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 12. US Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 16. Germany Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 17. France Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 24. China Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 28. India Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 30. Brazil Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cancer Gene Therapy Revenue Market Share, 2016-2027
Figure 33. Turkey Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cancer Gene Therapy Revenue, (US$, Mn), 2016-2027
Figure 37. Adaptimmune Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Bluebird bio Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Celgene Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Shanghai Sunway Biotech Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. SynerGene Therapeutics Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Altor BioScience Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Amgen Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Argenx Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. BioCancell Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. GlaxoSmithKline Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Merck Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Transgene Cancer Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs